Literature DB >> 10639348

Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Y Sáenz1, M Zarazaga, M Lantero, M J Gastanares, F Baquero, C Torres.   

Abstract

Colonization by Campylobacter strains was investigated in human, broiler, and pig fecal samples from 1997-1998, as well as in foods of animal origin, and antibiotic susceptibility testing was carried out for these strains. Campylobacter strains were isolated in the foods of animal origin (55 of 101 samples; 54.4%), intestinal samples from broilers (85 of 105; 81%), and pigs (40 of 45; 88.9%). A total of 641 Campylobacter strains were isolated from 8,636 human fecal samples of clinical origin (7.4%). Campylobacter jejuni was the most frequently isolated species from broilers (81%) and humans (84%), and Campylobacter coli was most frequently isolated from pigs (100%). An extremely high frequency of ciprofloxacin resistance was detected among Campylobacter strains, particularly those isolated from broilers and pigs (99%), with a slightly lower result for humans (72%); cross-resistance with nalidixic acid was almost always observed. A higher frequency of resistance to erythromycin (81.1%), ampicillin (65.7%), gentamicin (22.2%), and amikacin (21.6%) was detected in C. coli strains isolated from pigs compared to those isolated from humans (34.5, 29.3, 8.6, and 0%, respectively). A low frequency of erythromycin resistance was found in C. jejuni or C. coli isolated from broilers. A greater resistance to ampicillin and gentamicin (47.4 and 11.9%, respectively) was detected in C. jejuni isolated from broilers than in human strains (38 and 0.4%, respectively). Beta-lactamase production was found in 81% of the Campylobacter strains tested, although 44% of them were characterized as ampicillin susceptible. The increasing rates of Campylobacter resistance make advisable a more conservative policy for the use of antibiotics in farm animals.

Entities:  

Mesh:

Year:  2000        PMID: 10639348      PMCID: PMC89669          DOI: 10.1128/AAC.44.2.267-271.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

1.  Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens.

Authors:  A Svedhem; B Kaijser; E Sjögren
Journal:  J Antimicrob Chemother       Date:  1981-03       Impact factor: 5.790

2.  Analysis of distribution of Campylobacter jejuni and Campylobacter coli in broilers by using restriction fragment length polymorphism of flagellin gene.

Authors:  T Chuma; K Makino; K Okamoto; H Yugi
Journal:  J Vet Med Sci       Date:  1997-11       Impact factor: 1.267

3.  Aminoglycoside-phosphotransferases APH(3')-IV and APH(3") synthesized by a strain of Campylobacter coli.

Authors:  M J Rivera; J Castillo; C Martin; M Navarro; R Gomez-Lus
Journal:  J Antimicrob Chemother       Date:  1986-08       Impact factor: 5.790

4.  Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark.

Authors:  F M Aarestrup; F Bager; N E Jensen; M Madsen; A Meyling; H C Wegener
Journal:  APMIS       Date:  1998-06       Impact factor: 3.205

5.  Emergence of aminoglycoside 3-N-acetyltransferase IV in Escherichia coli and Salmonella typhimurium isolated from animals in France.

Authors:  E Chaslus-Dancla; J L Martel; C Carlier; J P Lafont; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

6.  Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada.

Authors:  C Gaudreau; H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

7.  Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  W Yan; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

8.  Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli.

Authors:  W L Wang; L B Reller; M J Blaser
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

9.  Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan.

Authors:  C C Li; C H Chiu; J L Wu; Y C Huang; T Y Lin
Journal:  Scand J Infect Dis       Date:  1998

10.  Erythromycin-resistant Campylobacter infections in Thailand.

Authors:  D N Taylor; M J Blaser; P Echeverria; C Pitarangsi; L Bodhidatta; W L Wang
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

View more
  46 in total

1.  Genetic relatedness and quinolone resistance of Campylobacter jejuni strains isolated in 2002 in Hong Kong.

Authors:  Yiu-Wai Chu; Man-Yu Chu; Kit-Yee Luey; Yin-Wa Ngan; Ka-Lok Tsang; Kai-Man Kam
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  PCR-restriction fragment length polymorphism assay for detection of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli.

Authors:  Rodrigo Alonso; Estibaliz Mateo; Cecilia Girbau; Estibaliz Churruca; Irati Martinez; Aurora Fernández-Astorga
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Prevalence and antibiotic susceptibility of thermophilic Campylobacter isolates from free range domestic duck (Cairina moschata) in Morogoro municipality, Tanzania.

Authors:  Hezron Emmanuel Nonga; A P Muhairwa
Journal:  Trop Anim Health Prod       Date:  2009-06-28       Impact factor: 1.559

4.  gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing.

Authors:  Antti Hakanen; Jari Jalava; Pirkko Kotilainen; Hannele Jousimies-Somer; Anja Siitonen; Pentti Huovinen
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Antimicrobial-resistant Campylobacter species from retail raw meats.

Authors:  Beilei Ge; David G White; Patrick F McDermott; Webb Girard; Shaohua Zhao; Susannan Hubert; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

6.  In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001.

Authors:  Rea Krausse; Uwe Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

7.  Prevalence and Antimicrobial Resistance of Campylobacter Isolated from Dressed Beef Carcasses and Raw Milk in Tanzania.

Authors:  Isaac P Kashoma; Issmat I Kassem; Julius John; Beda M Kessy; Wondwossen Gebreyes; Rudovick R Kazwala; Gireesh Rajashekara
Journal:  Microb Drug Resist       Date:  2015-07-08       Impact factor: 3.431

8.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

9.  Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.

Authors:  A Hakanen; P Kotilainen; P Huovinen; H Helenius; A Siitonen
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

10.  Phenotypic and Genotypic Antimicrobial Resistance Profiles of Campylobacter jejuni Isolated from Cattle, Sheep, and Free-Range Poultry Faeces.

Authors:  Beatriz Oporto; Ramón A Juste; Ana Hurtado
Journal:  Int J Microbiol       Date:  2010-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.